Geode Capital Management’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7M | Buy |
5,994,798
+864,194
| +17% | +$1.69M | ﹤0.01% | 2256 |
|
|
2025
Q1 | $9.03M | Buy |
5,130,604
+179,409
| +4% | +$316K | ﹤0.01% | 2353 |
|
|
2024
Q4 | $13.2M | Buy |
4,951,195
+922,503
| +23% | +$2.45M | ﹤0.01% | 2188 |
|
|
2024
Q3 | $9.23M | Buy |
4,028,692
+196,247
| +5% | +$449K | ﹤0.01% | 2432 |
|
|
2024
Q2 | $11.2M | Buy |
3,832,445
+705,247
| +23% | +$2.06M | ﹤0.01% | 2251 |
|
|
2024
Q1 | $11.4M | Buy |
3,127,198
+80,873
| +3% | +$294K | ﹤0.01% | 2254 |
|
|
2023
Q4 | $4.6M | Buy |
3,046,325
+146,203
| +5% | +$221K | ﹤0.01% | 2748 |
|
|
2023
Q3 | $3.89M | Buy |
2,900,122
+169,412
| +6% | +$227K | ﹤0.01% | 2768 |
|
|
2023
Q2 | $4.92M | Buy |
2,730,710
+342,435
| +14% | +$616K | ﹤0.01% | 2682 |
|
|
2023
Q1 | $3.96M | Buy |
2,388,275
+69,241
| +3% | +$115K | ﹤0.01% | 2737 |
|
|
2022
Q4 | $4.45M | Buy |
2,319,034
+45,718
| +2% | +$87.8K | ﹤0.01% | 2725 |
|
|
2022
Q3 | $5.09M | Buy |
2,273,316
+270,082
| +13% | +$605K | ﹤0.01% | 2668 |
|
|
2022
Q2 | $6.49M | Sell |
2,003,234
-270,237
| -12% | -$876K | ﹤0.01% | 2551 |
|
|
2022
Q1 | $12M | Buy |
2,273,471
+115,891
| +5% | +$610K | ﹤0.01% | 2235 |
|
|
2021
Q4 | $18.3M | Buy |
2,157,580
+748,225
| +53% | +$6.36M | ﹤0.01% | 2011 |
|
|
2021
Q3 | $14M | Buy |
1,409,355
+605,416
| +75% | +$6.02M | ﹤0.01% | 2211 |
|
|
2021
Q2 | $7.48M | Buy |
803,939
+282,357
| +54% | +$2.63M | ﹤0.01% | 2660 |
|
|
2021
Q1 | $5.45M | Buy |
+521,582
| New | +$5.45M | ﹤0.01% | 2752 |
|